vs
Side-by-side financial comparison of Danaos Corp (DAC) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $262.2M, roughly 1.0× Danaos Corp). Danaos Corp runs the higher net margin — 49.9% vs 0.7%, a 49.2% gap on every dollar of revenue. On growth, Danaos Corp posted the faster year-over-year revenue change (6.4% vs -16.5%).
Danaos Corporation is a leading global containership ownership and management firm. It operates a large fleet of modern container vessels, providing long-term charter services to top international container liner operators across major global trade routes, supporting the efficiency and reliability of global supply chains.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
DAC vs HCM — Head-to-Head
Income Statement — Q2 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $262.2M | $270.8M |
| Net Profit | $130.9M | $2.0M |
| Gross Margin | — | 37.7% |
| Operating Margin | 47.9% | -13.2% |
| Net Margin | 49.9% | 0.7% |
| Revenue YoY | 6.4% | -16.5% |
| Net Profit YoY | -7.3% | -83.6% |
| EPS (diluted) | $7.12 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $270.8M | ||
| Q2 25 | $262.2M | $277.7M | ||
| Q1 25 | — | $324.5M | ||
| Q2 24 | $246.3M | $305.7M | ||
| Q2 23 | $241.5M | $532.9M | ||
| Q2 22 | $250.9M | $202.0M |
| Q4 25 | — | $2.0M | ||
| Q2 25 | $130.9M | $455.0M | ||
| Q1 25 | — | $11.9M | ||
| Q2 24 | $141.2M | $25.8M | ||
| Q2 23 | $147.0M | $168.6M | ||
| Q2 22 | $8.2M | $-162.9M |
| Q4 25 | — | 37.7% | ||
| Q2 25 | — | 0.1% | ||
| Q1 25 | — | 48.0% | ||
| Q2 24 | — | 41.1% | ||
| Q2 23 | — | 0.0% | ||
| Q2 22 | — | 0.1% |
| Q4 25 | — | -13.2% | ||
| Q2 25 | 47.9% | -1.3% | ||
| Q1 25 | — | -5.0% | ||
| Q2 24 | 56.8% | -9.0% | ||
| Q2 23 | 61.1% | 21.0% | ||
| Q2 22 | 62.5% | -97.4% |
| Q4 25 | — | 0.7% | ||
| Q2 25 | 49.9% | 163.8% | ||
| Q1 25 | — | 3.7% | ||
| Q2 24 | 57.3% | 8.4% | ||
| Q2 23 | 60.9% | 31.6% | ||
| Q2 22 | 3.3% | -80.6% |
| Q4 25 | — | $0.00 | ||
| Q2 25 | $7.12 | $0.52 | ||
| Q1 25 | — | $0.01 | ||
| Q2 24 | $7.23 | $0.03 | ||
| Q2 23 | $7.32 | $0.19 | ||
| Q2 22 | $0.40 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $654.1M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $3.6B | $1.2B |
| Total Assets | $4.5B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $1.4B | ||
| Q2 25 | $654.1M | $1.4B | ||
| Q1 25 | — | $836.1M | ||
| Q2 24 | $471.7M | $802.5M | ||
| Q2 23 | $367.9M | $856.2M | ||
| Q2 22 | $319.6M | $826.2M |
| Q4 25 | — | $93.2M | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q2 24 | — | $82.1M | ||
| Q2 23 | — | $40.1M | ||
| Q2 22 | — | $418.0K |
| Q4 25 | — | $1.2B | ||
| Q2 25 | $3.6B | $1.2B | ||
| Q1 25 | — | $759.9M | ||
| Q2 24 | $3.3B | $740.1M | ||
| Q2 23 | $2.8B | $782.0M | ||
| Q2 22 | $2.4B | $799.7M |
| Q4 25 | — | $1.8B | ||
| Q2 25 | $4.5B | $1.8B | ||
| Q1 25 | — | $1.3B | ||
| Q2 24 | $4.0B | $1.3B | ||
| Q2 23 | $3.5B | $1.3B | ||
| Q2 22 | $3.7B | $1.2B |
| Q4 25 | — | 0.08× | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q2 24 | — | 0.11× | ||
| Q2 23 | — | 0.05× | ||
| Q2 22 | — | 0.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.2M |
| Free Cash FlowOCF − Capex | — | $3.4M |
| FCF MarginFCF / Revenue | — | 1.2% |
| Capex IntensityCapex / Revenue | — | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $8.2M | ||
| Q2 25 | — | $-72.9M | ||
| Q1 25 | — | $40.3M | ||
| Q2 24 | — | $-39.8M | ||
| Q2 23 | — | $226.4M | ||
| Q2 22 | — | $-89.9M |
| Q4 25 | — | $3.4M | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q2 24 | — | $-49.9M | ||
| Q2 23 | — | $202.0M | ||
| Q2 22 | — | $-105.6M |
| Q4 25 | — | 1.2% | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q2 24 | — | -16.3% | ||
| Q2 23 | — | 37.9% | ||
| Q2 22 | — | -52.3% |
| Q4 25 | — | 1.8% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q2 24 | — | 3.3% | ||
| Q2 23 | — | 4.6% | ||
| Q2 22 | — | 7.8% |
| Q4 25 | — | 4.21× | ||
| Q2 25 | — | -0.16× | ||
| Q1 25 | — | 3.38× | ||
| Q2 24 | — | -1.54× | ||
| Q2 23 | — | 1.34× | ||
| Q2 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
